Daniel Mulkerin is an Oncology physician affiliated with University of Rochester Medical Center. OpenAlex indexes 123 publications with 2,698 citations (h-index 24); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave
Rochester, NY 146425958
Telephone
585-275-5823Provider last certified this registry record 3 Oct 2022.
Clinical trials
- Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
Sponsor: University of Wisconsin, Madison
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.4%Phenothiazine40.4%Prochlorperazine Maleate100%Part D≥17 patientsMetabolism & gastrointestinal
34.6%Serotonin-3 Receptor Antagonist34.6%Ondansetron Hcl100%Part D≥16 patientsCancer & immunology
25%Nucleoside Analog Antiviral25%Lonsurf100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity
Scientific Reports
2025 - Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis
Journal of Gastrointestinal Oncology
2021 - A Study of Advanced Practice Provider Staffing Models and Professional Development Opportunities at National Comprehensive Cancer Network Member Institutions
Journal of the Advanced Practitioner in Oncology
2021 - Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity
bioRxiv (Cold Spring Harbor Laboratory)
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”